Overview

Is It Atrial Fibrillation? Navigating Uncertainties on When and Whom to Screen in the Primary Care Setting

Click the"View Activity" button to view this activity.

View Activity

Activity already occured. CME/CE is no longer available for this activity

Format

Game-based Education (powered by ACHL CrossMED)

Time to Complete

0.75 hr(s).

Release Date

March 22, 2024

Expires On

March 22, 2025

Atrial fibrillation (AF) is often asymptomatic making it difficult to detect and diagnose. Unfortunately, for many patients, a diagnosis of AF only follows a hospitalization for an acute event. Both targeted screening and opportunistic screening in the primary care setting can increase the rate of detection of new cases of AF, but are you current with the latest evidence? If you're a puzzle enthusiast, dive into this unique educational experience with CrossMED™! This engaging activity combines clue-based crosswords with word games to test your knowledge. Then, immerse yourself in expert videos, resources, and supporting data to increase your proficiency in screening practices to support early diagnosis while optimizing referrals of at-risk patients. Support better outcomes for your patients through this fun and engaging learning opportunity today!

This activity is intended for the multidisciplinary team practicing in primary care and/or geriatric practice.

Atrial fibrillation (AF) is the most common type of heart arrythmia and continues to contribute to over 454,000 hospitalizations and 158,000 deaths in the US every year. In addition, estimates suggests that there are at least 6.5 million Americans with AF, with projections reaching 12.1 million cases in 2030. .AF increases the risk of ischemic stroke 2.5-fold, and recent estimates show that 11% to 23% of cases are undiagnosed in the US Considering the prevalence of AF, and the fact that it is often asymptomatic, primary care providers (PCPs) need to better understand the burden and potential consequences of this condition to increase their urgency in detecting AF.

To enhance detection, PCPs must stay current with the latest recommendations and evidence for AF screening and need to be aware of the nuanced differences among a wide range of guideline recommendations. Moreover, it is critical for PCPs to know how to distinguish among the plethora of screening technologies currently available for AF.

Upon completion of this activity, learners will be able to:
• Describe recent evidence demonstrating the prevalence of undiagnosed NVAF
• Identify high-risk patients who are eligible for NVAF screening
• Introduce strategies to improve identification of undiagnosed NVAF to help reduce the risk of preventable stroke

Provided by the Academy for Continued Healthcare Learning (ACHL).

Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.

Elaine Hylek, MD, MPH
Professor of Medicine
Boston University Chobanian and Avedisian School of Medicine
Director, Anticoagulation and Thrombosis Service
Boston Medical Center
Boston, MA

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with all ineligible companies. All relevant financial relationships have been mitigated prior to this activity.

The following financial relationships have been provided:

Elaine Hylek, MD, MPH

Sources of Funding for Research: Abbott, Anthos Therapeutics, Medtronic

Steering Committee: Abbott, Medtronic

Data and Safety Monitoring Board: Anthos Therapeutics

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

This activity will take approximately 45 minutes to complete. To receive credit, learners are required to complete the pretest, view the online activity, and complete the posttest and evaluation. To receive credit, 75% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician assistants, nurse practitioners, and nurses may participate in this educational activity and earn a certificate of completion as AAPA, AANP, and ANCC accept AMA PRA Category 1 Credits™ through their reciprocity agreements.

Katie Hacias
khacias@achlcme.org
Phone: (773)714-0705 ext. 159

Overview

Is It Atrial Fibrillation? Navigating Uncertainties on When and Whom to Screen in the Primary Care Setting

Program Description

Intended Audience

Activity Purpose

Learning Objectives

Provider Information

Supporter Information

Faculty

Faculty Disclosure

Staff Disclosure

Disclaimer

Method of Participation

Accreditation and Credit Designation

Program Manager

Related Activities